237 results on '"Cobo S"'
Search Results
2. Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer
3. Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum Sacc & magn Scrib., patógeno de la antracnosis del frijol, en Colombia Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum (Sacc & Magn) Scrib., patógeno de la antracnosis del fríjol, en Colombia
4. P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial
5. SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
6. 237MO TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy
7. Reporte de casos:: leucemia/linfoma de células T del adulto asociada al virus HTLV-1
8. 234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study
9. 114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies
10. 218P Characteristics and outcomes of HER2-low (H-Low) and HER2-zero (H-0) advanced breast cancer (ABC) patients (pts) from GEICAM/2014-03 (RegistEM) registry
11. 126MO HER2DX and pathological complete response in HER2-positive breast cancer: A combined analysis of 4 neoadjuvant studies
12. Ecology and recovery plans for the four Spanish endangered endemic butterfly species
13. 216P Relationship between regulatory T lymphocytes (Treg): Related genes and pathological response to neoadjuvant docetaxel-carboplatin in early-stage triple-negative breast cancer (TNBC)
14. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms
15. 141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel
16. Revisión sobre la lesión de la musculatura isquiotibial en el deporte: factores de riesgo y estrategias para su prevención
17. 281P Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays
18. 261P Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact
19. 258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC)
20. Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses
21. 85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study
22. 62P Outcomes of high-risk breast cancer (BC) patients from El Álamo IV registry and GEICAM adjuvant clinical trials
23. Outcomes of high-risk breast cancer (BC) patients from El Alamo IV registry and GEICAM adjuvant clinical trials
24. 233P Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital
25. 406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC
26. 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
27. SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
28. TDS study of deuterium distribution in 3$^{rd}$ generation high strength steels as a function of charging conditions and cold rolling
29. Activity of chemotherapy drugs in patient-derived xenografts (PDXs) from chemotherapy naïve local-regional triple negative breast cancer (LR-TNBC) patients
30. SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
31. Hydrogen distribution in 3rd generation high strength steels and its effect on mechanical properties
32. Hydrogen distribution in a MnAl high strength steel and its effect on mechanical properties
33. Etude de la distribution de l'hydrogene incorpore a haute temperature dans un acier MnAl et son effet sur les proprietes mecaniques
34. Advanced Cleanliness Control in the 2nd Generation of Press Hardened Steels Produced by ArcelorMittal
35. The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
36. Bidirectional light-induced conductance switching in molecular wires containing a dimethyldihydropyrene unit
37. Validation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients
38. Breast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms
39. Safety and immunobiological activity of intratumoral (IT) double-stranded RNA (dsRNA) BO-112 in solid malignancies: First in human clinical trial
40. 53P - Activity of chemotherapy drugs in patient-derived xenografts (PDXs) from chemotherapy naïve local-regional triple negative breast cancer (LR-TNBC) patients
41. Deformation substructure of austenite evaluated by crystallographic reconstruction and its influence on microstructure inheritance in low carbon steels
42. Electrochemical control of the switching process of photochromic dimethyldihydropyrene derivatives
43. 942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
44. Soporte nutricional y factores de riesgo de aparición de fístulas enterocutáneas
45. Soporte nutricional y factores de riesgo de aparición de fístulas enterocutáneas
46. PKP-009 Evaluation of a population pharmacokinetic model of infliximab in rheumatoid arthritis for prediction of individual dosage requirements
47. PKP-011 Amikacin accumulation in patients with normal renal function and once daily dosing based on accepted trough targets
48. Self-assembled dimethyldihydropyrene-pyridyl substituted ligands with zinc(ii) meso-tetraphenylporphyrin via axial coordination
49. Heart Rate Variability: a Follow-up in Elite Soccer Players Throughout the Season
50. 30 CD56 bright natural killer cells primed by innate immune cytokines dominate the immune response stimulated by BCG to non-muscle invasive bladder cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.